Quest Diagnostics
553 hedge funds and large institutions have $10.7B invested in Quest Diagnostics in 2015 Q1 according to their latest regulatory filings, with 88 funds opening new positions, 171 increasing their positions, 195 reducing their positions, and 44 closing their positions.
100% more first-time investments, than exits
New positions opened: 88 | Existing positions closed: 44
10% more capital invested
Capital invested by funds: $9.72B → $10.7B (+$1B)
7% more funds holding
Funds holding: 517 → 553 (+36)
4% less call options, than puts
Call options by funds: $142M | Put options by funds: $148M
3.55% less ownership
Funds ownership: 100.27% → 96.72% (-3.5%)
7% less funds holding in top 10
Funds holding in top 10: 15 → 14 (-1)
12% less repeat investments, than reductions
Existing positions increased: 171 | Existing positions reduced: 195
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$128M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$63.6M |
| 3 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
+$43.9M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$42.8M |
| 5 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$40.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$159M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$134M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
-$126M |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$102M |
| 5 |
Millennium Management
New York
|
-$86.5M |
DGX Hedge Fund Activity: Q1 2015 in Review
553 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q1 2015, worth a combined $10.7B — up 10% from $9.72B a quarter earlier.
Buyers outnumbered sellers: 88 funds opened new DGX positions and 44 closed out — a net gain of 44 holders — while 171 added to existing stakes and 195 trimmed.
The largest buyer was BlackRock Advisors, adding an estimated $128M. The largest seller was Citadel Advisors, cutting an estimated $159M.
- 553 institutional investors held Quest Diagnostics (DGX) as of Q1 2015, up from 517 in Q4 2014.
- Funds reported $10.7B of Quest Diagnostics stock for Q1 2015, up 10% quarter-over-quarter.
- 88 funds opened new Quest Diagnostics positions in Q1 2015 and 44 closed out, a net change of +44 holders.
- The largest Quest Diagnostics buyer in Q1 2015 was BlackRock Advisors, an estimated $128M added.
- The largest Quest Diagnostics seller in Q1 2015 was Citadel Advisors, an estimated $159M sold.
Based on aggregated 13F filings for Q1 2015.